Deviation handling often determines whether quality systems demonstrate control or reveal recurring gaps during routine oversight and formal inspection review. This session structures investigation rigor, CAPA sustainability, and change control discipline into an integrated process aligned with 21 CFR 820.100 expectations.
Designed for professionals accountable for investigation quality, corrective action effectiveness, and controlled system change.
📅 March 11, 2026 | 🕒 11 AM Eastern Time US | 🕒 3 PM GMT | ⌛ 2 Hours
The session begins with deviation classification and investigation scoping, then progresses into structured root cause methods and evidence-based reporting. It connects corrective action development to effectiveness checks and change control governance, concluding with trending and metrics that reinforce long-term oversight and continuous improvement.
✔ Deviation and nonconformance management workflows
✔ Structured root cause analysis methods
✔ Writing investigation reports supported by evidence
✔ CAPA development, implementation, and effectiveness checks
✔ Risk assessment tools supporting corrective actions
✔ Change control requirements and governance discipline
✔ Trending, metrics, and sustained inspection readiness under 21 CFR 820.100
Course Director
Charles H. Paul
Charles H. Paul brings over 25 years of experience advising regulated manufacturers on investigation systems, documentation controls, and operational compliance. His consulting work includes strengthening deviation processes, CAPA programs, and change management systems across pharmaceutical and medical device organizations, supporting structured, evidence-based quality oversight aligned with regulatory expectations.
Your registration is managed by our events team to ensure a coordinated and seamless experience.